Skip to main content

Table 2 The complications and side effect occurred in the EUS-LA and US-LA groups

From: Treatment response and preliminary efficacy of hepatic tumour laser ablation under the guidance of percutaneous and endoscopic ultrasonography

  US-LA (n = 100) EUS-LA (n = 20) p value
Side effect 5 (5.0%) 3 (15.0%) 0.102
 PONV 0 (0%) 2 (10.0%) 0.001
 Abdominal pain 4 (4.0%) 1 (5.0%) 0.838
 Post-ablation fever 1 (1.0%) 0 (0%) 1.000
Major complication 1 (1.0%) 0 (0%) 1.000
 Sub-capsular haemobilia 1 (1.0%) 0 (0%) 1.000
  1. PONV post-operative nausea and vomiting, EUS endoscopic ultrasonography, US ultrasonography; LA laser ablation